Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Healthpeak Properties logoHealthpeak Properties DOC

The company said John Thomas, its Vice Chair, is scheduled to join a panel discussion at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 8 a.m. Pacific Time.

8-KRegulation FD DisclosureFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said John Thomas, its Vice Chair, is scheduled to join a panel discussion at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 8 a.m. Pacific Time.

  2. It said a live webcast of the presentation can be accessed on its website at https://ir.healthpeak.com/news-events/default.aspx at the time of the presentation.

  3. It said a replay of the presentation will be available on its website through May 15, 2026.

  4. The company reported the attendance schedule under Item 7.01, Regulation FD Disclosure, of its Form 8-K current report dated May 12, 2025. The report was signed by Kelvin O. Moses, Chief Financial Officer.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

BofA Securities 2025 Healthcare Conference Panel Participation

The company said John Thomas, its Vice Chair, is scheduled to join a panel discussion at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 8 a.m. Pacific Time.

Source · Based on the filing body and exhibits

Live Webcast of Presentation Available

It said a live webcast of the presentation can be accessed on its website at https://ir.healthpeak.com/news-events/default.aspx at the time of the presentation.

Source · Based on the filing body and exhibits

Replay Availability Deadline

It said a replay of the presentation will be available on its website through May 15, 2026.

Source · Based on the filing body and exhibits

Item 7.01 Regulation FD Disclosure Filing

The company reported the attendance schedule under Item 7.01, Regulation FD Disclosure, of its Form 8-K current report dated May 12, 2025. The report was signed by Kelvin O. Moses, Chief Financial Officer.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.